C-terminal α-MSH tripeptide fragment investigated for anti-inflammatory and intestinal-barrier research.
Purity
99%+
CAS Number
61512-21-8
Status
In Stock
Dispatch
Same-Day (before 2pm)
Select Size
£199.99
Research verification required. All orders are reviewed before dispatch. You will receive an email confirmation and a WhatsApp or phone call within 60 minutes to verify your research purpose.
KPV is the C-terminal tripeptide fragment (residues 11-13) of α-melanocyte-stimulating hormone, comprising lysine, proline and valine. It has been extensively investigated for anti-inflammatory signalling at melanocortin pathways, with particular focus on gut-barrier integrity, colitis models and cytokine modulation. Supplied as lyophilised powder for in vitro laboratory research only.
| Compound Name | KPV |
| Category | Healing & Recovery |
| CAS Number | 61512-21-8 |
| Molecular Weight | 342.44 g/mol |
| Molecular Formula | C₁₆H₃₀N₄O₄ |
| Sequence | Lys-Pro-Val (α-MSH 11-13 fragment) |
| Purity | ≥99%+ (HPLC) |
| Form | Lyophilised powder |
| Storage | Store lyophilised at -20°C. Protect from light. Reconstituted: aliquot and store at -80°C. Use within 30 days of reconstitution. |
| Reconstitution | Reconstitute in bacteriostatic or sterile water. Typical stock concentration: 1 mg/mL. |
Every order of KPV includes a batch-specific CoA with HPLC chromatogram, mass spectrometry data, and laboratory accreditation details.
KPV is the C-terminal tripeptide fragment of α-MSH (Lys-Pro-Val). It is studied in laboratory research for anti-inflammatory signalling, intestinal-barrier biology and melanocortin-pathway activity.
99%+, confirmed by independent third-party HPLC analysis. Batch-specific CoA included.
No. Supplied for in vitro laboratory research only. Not a licensed medicine.
KPV is supplied by Premio Peptides (BELL RED LIMITED) exclusively for in vitro laboratory research. It is not a licensed medicine, is not approved for human or veterinary use, and must not be administered to any living organism outside a formally approved research protocol. Purchasers assume full responsibility for compliance with applicable regulations.
